The increased tumor burden was associated with aberrant p62 mutant aggregates and Nrf2 overactivation, but not with other protumorigenic functions of p62 through regulation of fibrosis, cMYC expression or mTOR activity. The gene discussed is MYC; the disease is neoplasm.